REFERENCES
- Poehlmann A, Kuester D, Malfertheiner P, et al. Inflammation and Barrett’s carcinogenesis. Pathol Res Pract 2012;208:269–80
- Nelsen EM, Hawes RH, Iyer PG. Diagnosis and management of Barrett’s esophagus. Surg Clin North Am 2012;92:1135–54
- Cameron AJ, Souto EO, Smyrk TC. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol 2002;97:1375–80
- Oberg S, Wenner J, Johansson J, et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005;242:49–54
- Bobryshev YV, Killingsworth MC, Lord RV. Structural alterations of the mucosa stroma in the Barrett’s esophagus metaplasia–dysplasia–adenocarcinoma sequence. J Gastroenterol Hepatol 2012;27:1498–504
- Phillips WA, Lord RV, Nancarrow DJ, et al. Barrett’s esophagus. J Gastroenterol Hepatol 2011;26:639–48
- Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982–93
- Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220–41
- Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446–56
- Lawler K, Foran E, O’Sullivan G, et al. Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 2006;291:C668–77
- Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003;5:711–19
- Charras GT, Yarrow JC, Horton MA, et al. Non-equilibration of hydrostatic pressure in blebbing cells. Nature 2005;435:365–9
- Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs) potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 2011;32:167–73
- Segain JP, Raingeard de la Blétière D, Sauzeau V, et al. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn’s disease and experimental colitis. Gastroenterology 2003;124:1180–7
- Mihaescu A, Santén S, Jeppsson B, Thorlacius H. Rho kinase signalling mediates radiation-induced inflammation and intestinal barrier dysfunction. Br J Surg 2011;98:124–31
- Feagins LA, Zhang HY, Zhang X, et al. Mechanisms of oxidant production in esophageal squamous cell and Barrett’s cell lines. Am J Physiol Gastrointest Liver Physiol 2008;294:G411–17
- Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 2004;287:H1495–500
- Oguz E, Alasehirli B, Pehlivan Y, et al. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet’s disease. Transl Res 2012;160:428–34
- Sari I, Berberoglu B, Ozkara E, et al. Role of Rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. Pathobiology 2013;80:138–45
- Zhou J, Zhao LQ, Xiong MM, et al. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003;9:9–15
- Pretto G, Gurski RR, Binato M, et al. Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus. Dig Dis Sci 2013;58:115–22
- Nakashima M, Adachi S, Yasuda I, et al. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Mol Cancer 2011;10:79
- Zampeli E, Karamanolis G, Morfopoulos G, et al. Increased expression of VEGF, COX-2, and Ki-67 in Barrett’s esophagus: does the length matter? Dig Dis Sci 2012;57:1190–6
- Griffiths EA, Pritchard SA, McGrath SM, et al. Increasing expression of hypoxia-inducible proteins in the Barrett’s metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer 2007;96:1377–83
- Bryan BA, Dennstedt E, Mitchell DC, et al. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J 2010;24:3186–95
- Wang L, Xue L, Yan H, et al. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep 2010;37:1971–7
- Couvelard A, Paraf F, Gratio V, et al. Angiogenesis in the neoplastic sequence of Barrett’s oesophagus: correlation with VEGF expression. J Pathol 2000;192:14–18